If you or a loved one takes antipsychotics, here are five key facts about tardive dyskinesia—a common, often-overlooked ...

Dr. Evan Chavers and Dr. Shyla Hossain from Accordia Health joined WKRG News 5’s The Doctor is In to discuss schizophrenia ...

A new study published in Nature Mental Health has found that people with a higher genetic risk for schizophrenia tend to have ...

Digital technology may be on the verge of ‘breaking out’ for schizophrenia treatment, but numerous questions will need to be answered about scalability and costs, experts say.

Often people with schizophrenia are offered treatment with more than one antipsychotic in order to achieve an effective treatment. Use of antipsychotics is connected with side effects, and the ...

Latest research at the Epilepsy Society using pioneering research equipment has shown parallels between people with ...

Psychiatrist Dr Nemal Gokool supports Prime Minister Kamla Persad-Bissessar’s move to raise the legal age for marijuana use ...

Johnson & Johnson submits sNDA to US FDA for Caplyta for prevention of relapse in schizophrenia: Titusville, New Jersey Wednesday, July 9, 2025, 14:00 Hrs [IST] Johnson & Johnson ...

Titusville: Johnson & Johnson has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug ...

Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to ...

Johnson & Johnson (JNJ) said on Tuesday that it has submitted a supplemental new drug application to the U.S. Food and Drug ...

The supplemental New Drug Application is supported by Phase III data, which showed Caplyta significantly prolonged time to ...